NCT04780178

Brief Summary

The purpose of the study is to test if Acceptance and Commitment Therapy (ACT), a behavioral intervention designed to increase psychological flexibility in the face of challenges, reduces anxiety associated psychological distress in dementia caregivers compared to the control group who will receive self-help and educational materials. This version of ACT is delivered over the phone in six primary sessions and one booster session.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2022

Completed
Last Updated

September 1, 2022

Status Verified

August 1, 2022

Enrollment Period

1.4 years

First QC Date

February 25, 2021

Last Update Submit

August 31, 2022

Conditions

Keywords

DementiaAlzheimer's diseaseCaregivingCaregiverAnxietyTelehealth

Outcome Measures

Primary Outcomes (1)

  • Generalized Anxiety Disorder Scale (GAD-7)

    The Generalized Anxiety Disorder Scale (GAD-7) contains 7 items with total scores ranging from 0 to 21. Scores of 5, 10, and 15 are cut-offs for mild, moderate, and severe anxiety, respectively. An add-on item assessing the patient's global impression of symptom-related impairment helps researchers understand the extent to which anxiety interferes in daily life. The GAD-7 has factorial validity for the diagnosis of general anxiety disorder and is sensitive to change.

    Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month

Other Outcomes (10)

  • Patient Health Questionnaire-8

    Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month

  • Zarit Burden Interview

    Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month

  • Experience of Suffering Scale

    Baseline, post-intervention (7-9 weeks post-baseline), 3-month, 6-month

  • +7 more other outcomes

Study Arms (2)

TACTICs

EXPERIMENTAL

Our ACT intervention will include 6 weekly 1-hour telephone sessions and 1 booster session offered 1 month after session 6 designed to increase psychological flexibility through practice of one or more of the six skills in each session. Although these are ideally spaced 1 week apart, participants will have up to 12 weeks to complete the 6 sessions. Each session will include guided mindfulness practice that encourages non-judgmental awareness of the present moment to increase psychological flexibility; brief (10-minute) study-provided audio recordings will enable participants to practice mindfulness at home. Caregivers will also identify deeply-held values to serve as a guide when choosing how to spend limited time or energy and will set values-based action goals each week. A booster session will be provided one month after session 6 to reinforce skills learned.

Behavioral: Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults with Alzheimer's Disease and Related Dementias

Minimally Enhanced Usual Care

NO INTERVENTION

All caregivers randomized to the mEUC group will receive a mailed packet containing 1) a letter from the Co-PIs thanking them for participating, 2) printed selections from of the NIH Alzheimer's caregiving website (https://www.nia.nih.gov/health/alzheimers/caregiving), and 3) a listing of Alzheimer's Association sponsored support groups closest to the caregiver's home address. Caregivers will also receive a brief phone call from the research coordinator to verify receipt of the packet. Since this is a usual care group with a minimally-enhanced component, it will be up to the mEUC participants to decide whether or not to engage with these intervention materials.

Interventions

A telephone-based acceptance and commitment therapy for caregivers

Also known as: TACTICs
TACTICs

Eligibility Criteria

Age21 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Listed in ADRD patient's chart as primary caregiver or self-identifies as ADRD patient's primary caregiver
  • Intends to continue caregiving for ≥12 months
  • Clinically-significant anxiety (score ≥10 on GAD-7)
  • years or older
  • Able to communicate in English
  • Able to provide informed consent

You may not qualify if:

  • Caregiver is a non-family member
  • Care recipient is in an assisted living or nursing home (at baseline)
  • Has ADRD or other serious mental illness diagnosis such as schizophrenia as determined by ICD-10 code or self-report
  • Caregiver is enrolled in an existing ADRD collaborative program at Eskenazi Health, IU Health or the VA.
  • Caregiver is enrolled in another IU study that is testing a ADRD caregiver intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IUH

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Anxiety DisordersCaregiver BurdenDementiaAlzheimer Disease

Interventions

Amyloid beta-Protein Precursor

Condition Hierarchy (Ancestors)

Mental DisordersStress, PsychologicalBehavioral SymptomsBehaviorBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersTauopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Amyloidogenic ProteinsAmyloidProteinsAmino Acids, Peptides, and ProteinsMembrane ProteinsProtein PrecursorsProtease NexinsProteinase Inhibitory Proteins, Secretory

Study Officials

  • Nicole R Fowler, PhD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors are blinded to participant group assignment.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to receive either the TACTICs telephone therapy or the minimally enhanced usual care packet of information.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine

Study Record Dates

First Submitted

February 25, 2021

First Posted

March 3, 2021

Study Start

April 1, 2021

Primary Completion

August 8, 2022

Study Completion

August 8, 2022

Last Updated

September 1, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

In future manuscripts, the authors will list contact information and state that the IPD is available upon request

Locations